跳至主要内容
临床试验/NCT02089074
NCT02089074已完成不适用

Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack: Adherence and Cardiovascular Events in the First Three Months

Norwegian University of Science and Technology6 个研究点 分布在 1 个国家目标入组 265 人开始时间: 2012年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
265
试验地点
6
主要终点
adherence to drug treatment in secondary prevention after TIA

研究概览

简要总结

Use of drugs is an important factor in secondary prophylaxis after transient ischemic attack (TIA), but studies show that adherence to the prescribed drugs is often poor. This randomised controlled trial aims to investigate whether a systematic follow up of drug treatment using medication reconciliation, medication reviews and patient counselling by clinical pharmacists, improves adherence and/or decreases cardiovascular events the first three months and the first year after TIA. Patient satisfaction will also be compared between the two groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Probable or possible transient ischemic attack
  • •Residing in Central Norway
  • •Examined within 2 weeks after the onset of symptoms
  • •Modified Rankin Scale 3 or less and living at home
  • •enrolled in the MIDNOR-TIA study NCT02038725
  • •Informed consent

排除标准

  • 未提供

研究组 & 干预措施

drug use counselling

Experimental

Pharmacist conducting drug reconciliation, medication reviews and drug use counselling during hospitalisation. Follow up telephone calls 1 week, 1 month, 2 months and three months after discharge from hospital

干预措施: Drug use counselling (Behavioral)

Control group

No Intervention

The patients in the control group receive no intervention just treatment and follow up according to national standards

结局指标

主要结局

adherence to drug treatment in secondary prevention after TIA

时间窗: 3 months

self reporting of adherence

次要结局

  • adherence to drug treatment in secondary prevention after TIA(1 year)
  • Incidence of stroke and cardiovascular events and deaths(1 year)
  • patient satisfaction(1 year)
  • Persistence(1 year)
  • degree of disability or dependence in the daily activities(1 year)
  • Persistence(3 months)
  • Incidence of stroke and cardiovascular events and deaths(3 months)
  • degree of disability or dependence in the daily activities(3 months)
  • patient satisfaction(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验